Discovery of new chemical entities as potential leads against Mycobacterium tuberculosis
作者:Xiaoyun Lu、Jian Tang、Zhiyong Liu、Minke Li、Tianyu Zhang、Xiantao Zhang、Ke Ding
DOI:10.1016/j.bmcl.2016.11.003
日期:2016.12
A series of biheterocyclic (1H-indole, benzofuran, pyrazolo[1,5-a]pyrimidine, pyrazolo[1,5-a]pyrimidin-5(4H)-one, imidazo[2,1-b]thiazole and pyrazolo[5,1-b]thiazole) derivatives were synthesized and evaluated for their anti-tubercular activities. The imidazo[2,1-b]thiazoles 9a-c and pyrazolo[5,1-b]thiazoles 10a-c exhibited promising anti-tubercular activity in varying degrees. Especially, the 2,6-dimethylpyrazolo[5
一系列双杂环(1H-吲哚,苯并呋喃,吡唑并[1,5-a]嘧啶,吡唑并[1,5-a]嘧啶-5(4H)-one,咪唑并[2,1-b]噻唑和吡唑并[合成了5,1-b]噻唑)衍生物并评估了它们的抗结核活性。咪唑并[2,1-b]噻唑9a-c和吡唑并[5,1-b]噻唑10a-c在不同程度上表现出有希望的抗结核活性。特别地,2,6-二甲基吡唑并[5,1-b]噻唑10a具有对H37Ra菌株的强抑制作用,MIC值为0.03μg/ mL。化合物10a还显示出良好的药代动力学特征,口服生物利用度(F)为41.7%,半衰期为13.4h。此外,10a显着降低了自发光H37Ra感染的小鼠模型中的细菌负担,表明其开发抗结核药物的潜力很大。